HAE Haemonetics Corporation Common Stock

NYSE · Health Care · View on SEC EDGAR ↗

$56.07

Price · May 20, 2026

Fundamentals as of Feb 5, 2026

HAE Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price

$56.07

Market Cap

$3.05B

P/E (TTM)

19.1

EPS (TTM)

$3.31

Revenue (TTM)

$1.36B

Div Yield

—

ROE

19.4%

Debt/Equity

1.5

52W Range

$47 – $87

HAE Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income $1.36B

2016-04-02 → 2025-03-29

EPS $3.31

2016-04-02 → 2025-03-29

Free Cash Flow $142M

2016-04-02 → 2025-03-29

Margins 12.3%

2016-04-02 → 2025-03-29

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric

5Y trend

HAE

Peer Median

P/E (TTM)

19.1

25.5

P/S (TTM)

2.2

1.7

P/B

3.7

2.6

EV / EBITDA

17.9

—

Price / FCF

21.4

—

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric

5Y trend

HAE

Peer Median

Gross Margin

55.0%

54.9%

Operating Margin

16.3%

—

Net Profit Margin

12.3%

-8.7%

ROA

7.2%

-7.2%

ROE

19.4%

-11.1%

ROIC

8.6%

—

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric

5Y trend

HAE

Peer Median

Debt / Equity

1.5

37.4

Current Ratio

1.6

2.3

Quick Ratio

0.9

—

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric

5Y trend

HAE

Peer Median

Revenue YoY

4.0%

—

Revenue CAGR 3Y

11.1%

—

EPS YoY

44.5%

—

Net Income YoY

42.6%

—

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric

5Y trend

HAE

Peer Median

EPS (Diluted)

$3.31

—

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric

5Y trend

HAE

Peer Median

HAE Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 15 analysts

Strong Buy 4 26.7%
Buy 6 40.0%
Hold 5 33.3%
Sell 0 0.0%
Strong Sell 0 0.0%

12-Month Price Target

10 analysts · 2026-05-21

Median $78.00

← Below all targets $56.07

Low $62.00

High $104.00

Median target $78.00 +39.1%

Mean target $80.20 +43.0%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise

0.06%

Period	EPS Actual	EPS Est	Surprise
March 31, 2026	$1.29	$1.28	0.01%
Dec. 31, 2025	$1.31	$1.26	0.05%
Sept. 30, 2025	$1.27	$1.12	0.15%
June 30, 2025	$1.10	$1.03	0.07%
March 31, 2025	$1.24	$1.23	0.01%

Peer Comparison Key metrics vs sector peers

Ticker	Market Cap	P/E	Rev YoY	Net Margin	ROE	Gross Margin
HAE	$3.05B	19.1	4.0%	12.3%	19.4%	55.0%
LNTH	$4.30B	19.5	0.50%	15.2%	20.7%	61.1%
QDEL	$1.99B	-1.8	-1.9%	-41.4%	-48.0%	—
MMSI	$5.24B	41.4	11.8%	8.5%	8.4%	48.7%
MMED	—	—	—	—	—	—
ICUI	$3.52B	4755.7	-6.3%	0.03%	0.03%	36.8%
XRAY	$2.28B	-3.8	-3.0%	-16.2%	-36.4%	50.0%
NEOG	$1.27B	-1.2	-3.2%	-122.1%	-41.9%	47.1%
UFPT	$1.71B	25.4	19.5%	11.3%	16.9%	28.3%
STAA	$1.17B	-14.6	-23.7%	-33.6%	-23.6%	76.2%
AVNS	$522M	-7.2	1.9%	-10.4%	-9.1%	50.5%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Income Statement 16

Annual Income Statement data for HAE
Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue	$1.36B	$1.31B	$1.17B	$993M	$870M	$988M	$968M	$904M	$886M	$909M	$910M	$939M
Cost of Revenue	$612M	$618M	$554M	$488M	$473M	$504M	$550M	$492M	$508M	$503M	$476M	$470M
Gross Profit	$749M	$692M	$615M	$506M	$398M	$485M	$418M	$412M	$378M	$406M	$434M	$468M
R&D Expense	$63M	$54M	$50M	$47M	$33M	$31M	$36M	$39M	$38M	$45M	$54M	$54M
SG&A Expense	$437M	$432M	$377M	$340M	$275M	$282M	$273M	$317M	$302M	$317M	$337M	$366M
Operating Expenses	$527M	$527M	$459M	$425M	$308M	$381M	$334M	$356M	$398M	$450M	$394M	$422M
Operating Income	$222M	$165M	$156M	$81M	$90M	$103M	$84M	$56M	$-19M	$-44M	$41M	$46M
Other Non-op	$-10M	$-13M	$-15M	$-17M	$-17M	$-16M	$-10M	$-5M	$-8M	$-9M	$-9M	$-10M
Pretax Income	$212M	$152M	$141M	$64M	$73M	$87M	$74M	$60M	$-27M	$-53M	$31M	$36M
Income Tax	$44M	$34M	$26M	$20M	$-7M	$11M	$19M	$14M	$-1M	$2M	$14M	$1M
Net Income	$168M	$118M	$115M	$43M	$79M	$77M	$55M	$46M	$-26M	$-56M	$17M	$35M
EPS (Basic)	$3.33	$2.32	$2.27	$0.85	$1.57	$1.51	$1.07	$0.86	$-0.51	$-1.09	$0.33	$0.68
EPS (Diluted)	$3.31	$2.29	$2.24	$0.84	$1.55	$1.48	$1.04	$0.85	$-0.51	$-1.09	$0.32	$0.67
Shares (Basic)	50,330,000	50,706,000	50,783,000	51,047,000	50,688,000	50,692,000	51,533,000	52,755,000	51,524,000	50,910,000	51,533,000	51,611,000
Shares (Diluted)	50,730,000	51,397,000	51,420,000	51,353,000	51,292,000	51,815,000	52,942,000	53,501,000	51,524,000	50,910,000	52,089,000	52,377,000
EBITDA	$222M	$165M	$156M	$81M	$90M	$103M	$84M	$56M	$-19M	$-44M	$41M	$47M

Balance Sheet 26

Annual Balance Sheet data for HAE
Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Cash & Equivalents	$307M	$179M	$284M	$259M	$192M	$137M	$169M	$180M	$140M	$115M	$161M	$192M
Receivables	$203M	$207M	$179M	$159M	$128M	$165M	$185M	$151M	$153M	$157M	$146M	$165M
Inventory	$365M	$317M	$259M	$293M	$323M	$270M	$194M	$161M	$177M	$187M	$211M	$198M
Prepaid Expense	$60M	$66M	$47M	$44M	$51M	$31M	$27M	$29M	$41M	$29M	$40M	$54M
Current Assets	$935M	$769M	$770M	$756M	$694M	$604M	$576M	$521M	$510M	$488M	$558M	$623M
PP&E (Net)	$284M	$311M	$311M	$258M	$218M	$253M	$344M	$332M	$324M	$338M	$322M	$271M
PP&E (Gross)	$837M	$959M	$944M	$869M	$817M	$832M	$933M	$873M	$807M	$786M	$732M	$702M
Accum. Depreciation	$553M	$648M	$633M	$611M	$600M	$579M	$589M	$541M	$484M	$449M	$410M	$430M
Goodwill	$604M	$565M	$466M	$467M	$466M	$211M	$211M	$211M	$211M	$268M	$334M	$337M
Intangibles	$456M	$406M	$276M	$310M	$365M	$133M	$128M	$157M	$178M	$204M	$245M	$271M
Other Non-current Assets	$164M	$136M	$107M	$63M	$71M	$62M	$12M	$12M	$12M	$14M	$11M	$11M
Total Assets	$2.45B	$2.20B	$1.93B	$1.86B	$1.82B	$1.27B	$1.27B	$1.24B	$1.24B	$1.32B	$1.49B	$1.51B
Accounts Payable	$67M	$73M	$64M	$58M	$50M	$51M	$63M	$55M	$43M	$40M	$48M	$54M
Short-term Debt	·	·	·	·	·	·	·	·	·	·	·	$0
Current Liabilities	$578M	$300M	$252M	$442M	$253M	$275M	$236M	$385M	$211M	$186M	$189M	$217M
Capital Leases	$50M	$58M	$56M	$56M	$63M	$52M	·	·	·	·	·	·
Deferred Tax	$63M	$63M	$36M	$29M	$44M	$11M	$20M	$7M	$12M	$21M	$33M	$30M
Other Non-current Liabilities	$68M	$75M	$75M	$80M	$100M	$89M	$29M	$34M	$22M	$26M	$32M	$38M
Long-term Debt	$1.22B	$808M	$766M	$774M	$708M	$382M	$350M	$254M	$316M	$408M	$430M	$440M
Total Debt	$1.22B	$808M	$766M	$774M	$708M	$382M	$350M	$254M	$315M	$408M	$428M	$438M
Common Stock	$482.0K	$508.0K	$504.0K	$511.0K	$509.0K	$503.0K	$510.0K	$523.0K	$523.0K	$509.0K	$517.0K	$520.0K
Retained Earnings	$352M	$360M	$253M	$202M	$158M	$79M	$161M	$267M	$290M	$316M	$420M	$433M
AOCI	$-55M	$-36M	$-30M	$-26M	$-30M	$-45M	$-30M	$-19M	$-33M	$-35M	$-22M	$1M
Stockholders' Equity	$821M	$960M	$818M	$749M	$732M	$587M	$668M	$752M	$740M	$722M	$826M	$838M
Liabilities + Equity	$2.45B	$2.20B	$1.93B	$1.86B	$1.82B	$1.27B	$1.27B	$1.24B	$1.24B	$1.32B	$1.49B	$1.51B
Shares Outstanding	48,215,899	50,787,859	50,448,519	51,124,240	50,868,820	50,322,930	51,019,918	52,342,965	52,255,495	50,932,348	51,670,969	52,041,189

Cash Flow 16

Annual Cash Flow data for HAE
Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
D&A	$116M	$97M	$93M	$98M	$84M	$110M	$109M	$89M	$90M	$90M	$86M	$82M
Stock-based Comp	$30M	$28M	$26M	$24M	$26M	$20M	$17M	$13M	$9M	$7M	$14M	$13M
Deferred Tax	$-6M	$-11M	$6M	$5M	$-21M	$-7M	$13M	$-6M	$-7M	$-1M	$4M	$-202.0K
Amort. of Intangibles	$56M	$41M	$42M	$57M	$41M	$34M	$25M	$32M	$37M	$59M	$34M	$29M
Restructuring	$14M	$14M	$657.0K	$4M	$1M	$4M	$395.0K	$31M	$22M	$23M	$37M	$49M
Operating Cash Flow	$182M	$182M	$273M	$172M	$109M	$158M	$159M	$220M	$160M	$122M	$127M	$140M
CapEx	$39M	$38M	$191M	$97M	$37M	$49M	$119M	$75M	$76M	$102M	$122M	$74M
Investing Cash Flow	$-162M	$-322M	$-144M	$-86M	$-425M	$-57M	$-116M	$-63M	$-73M	$-105M	$-122M	$-106M
Debt Issued	·	·	·	·	·	$0	$348M	$0	$0	·	$0	$0
Net Debt Issued	$-5M	$-12M	$-10M	$-18M	$-22M	$-13M	$81M	$-62M	$-43M	$-21M	$-9M	$-37M
Stock Repurchased	$225M	$0	$75M	$0	$0	$175M	$160M	$100M	$0	$61M	$39M	$0
Net Stock Activity	$-225M	$0	$-75M	$0	$0	$-175M	$-160M	$-100M	$0	$-61M	$-39M	$0
Financing Cash Flow	$109M	$38M	$-100M	$-16M	$367M	$-131M	$-51M	$-121M	$-60M	$-63M	$-33M	$-21M
Net Change in Cash	$128M	$-106M	$25M	$67M	$55M	$-32M	$-11M	$41M	$24M	$-46M	$-32M	$13M
Taxes Paid	·	·	·	·	$12M	$12M	$8M	$9M	$7M	$8M	$11M	$7M
Free Cash Flow	$142M	$115M	$163M	$76M	$72M	$109M	$40M	$146M	$84M	$19M	$5M	$66M

Profitability 8

Annual Profitability data for HAE
Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Gross Margin	55.0%	52.8%	52.6%	50.9%	45.7%	49.0%	43.1%	45.6%	42.7%	44.7%	47.7%	49.9%
Operating Margin	16.3%	12.6%	13.4%	8.1%	10.3%	10.5%	8.6%	6.2%	-2.2%	-4.8%	4.5%	5.0%
Net Margin	12.3%	9.0%	9.9%	4.4%	9.1%	7.7%	5.7%	5.0%	-3.0%	-6.1%	1.9%	3.8%
Pretax Margin	15.6%	11.6%	12.1%	6.4%	8.4%	8.8%	7.6%	6.6%	-3.1%	-5.9%	3.4%	3.9%
EBITDA Margin	16.3%	12.6%	13.4%	8.1%	10.3%	10.5%	8.6%	6.2%	-2.2%	-4.8%	4.5%	5.0%
ROA	7.2%	5.7%	6.1%	2.4%	5.1%	6.0%	4.4%	3.7%	-2.1%	-4.0%	1.1%	2.4%
ROE	19.4%	12.3%	14.5%	5.9%	11.0%	13.2%	8.7%	6.1%	-3.6%	-7.2%	2.0%	4.4%
ROIC	8.6%	7.2%	8.0%	3.6%	6.8%	9.4%	6.1%	4.3%	-1.8%	-4.0%	1.8%	3.6%

Liquidity & Solvency 4

Annual Liquidity & Solvency data for HAE
Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Current Ratio	1.6	2.6	3.1	1.7	2.7	2.2	2.4	1.4	2.4	2.6	3.0	2.9
Quick Ratio	0.9	1.3	1.8	0.9	1.3	1.1	1.5	0.9	1.4	1.5	1.6	1.6
Debt / Equity	1.5	0.8	0.9	1.0	1.0	0.7	0.5	0.3	0.4	0.6	0.5	0.5
LT Debt / Equity	1.1	0.8	0.9	0.7	0.9	0.5	0.5	0.1	0.3	0.5	0.5	0.5

Efficiency 3

Annual Efficiency data for HAE
Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Asset Turnover	0.6	0.6	0.6	0.5	0.6	0.8	0.8	0.7	0.7	0.6	0.6	0.6
Inventory Turnover	1.8	2.1	2.0	1.6	1.6	2.2	3.1	2.9	2.8	2.5	2.3	2.5
Receivables Turnover	6.7	6.8	6.9	6.9	5.9	5.6	5.8	5.9	5.7	6.0	5.9	5.6

Per Share 5

Annual Per Share data for HAE
Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Book Value / Share	$17.02	$18.90	$16.21	$14.66	$14.38	$11.67	$13.09	$14.38	$14.15	$14.17	$15.99	$16.10
Revenue / Share	$26.82	$25.47	$22.73	$19.34	$16.97	$19.08	$18.28	$16.90	$17.20	$17.85	$17.48	$17.92
Cash Flow / Share	$3.58	$3.54	$5.31	$3.35	$2.12	$3.05	$3.01	$4.12	$3.10	$2.39	$2.44	$2.66
Cash / Share	$6.36	$3.52	$5.64	$5.08	$3.78	$2.73	$3.32	$3.44	$2.67	$2.26	$3.11	$3.70
EPS (TTM)	$3.31	$2.29	$2.24	$0.84	$1.55	$1.48	$1.04	$0.85	$-0.51	$-1.09	$0.32	$0.67

Growth Rates 6

Annual Growth Rates data for HAE
Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue YoY	4.0%	12.0%	17.7%	14.1%	·	·	·	·	·	·	·	·
Revenue CAGR 3Y	11.1%	14.6%	·	·	·	·	·	·	·	·	·	·
EPS YoY	44.5%	2.2%	166.7%	-45.8%	·	·	·	·	·	·	·	·
EPS CAGR 3Y	58.0%	13.9%	·	·	·	·	·	·	·	·	·	·
Net Income YoY	42.6%	1.9%	166.1%	-45.4%	·	·	·	·	·	·	·	·
Net Income CAGR 3Y	56.9%	13.9%	·	·	·	·	·	·	·	·	·	·

Valuation (TTM) 14

Annual Valuation (TTM) data for HAE
Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue TTM	$1.36B	$1.31B	$1.17B	$993M	$870M	$988M	$968M	$904M	$886M	$909M	$910M	$939M
Net Income TTM	$168M	$118M	$115M	$43M	$79M	$77M	$55M	$46M	$-26M	$-56M	$17M	$35M
Market Cap	$3.05B	$4.33B	$4.17B	$3.26B	$5.70B	$5.08B	$4.46B	$3.83B	$2.12B	$1.80B	$2.28B	$1.67B
Enterprise Value	$3.96B	$4.96B	$4.66B	$3.78B	$6.21B	$5.33B	$4.64B	$3.90B	$2.30B	$2.09B	$2.55B	$1.92B
P/E	19.1	37.3	36.9	76.0	72.3	68.2	84.1	86.1	-79.5	-32.4	138.2	47.9
P/S	2.2	3.3	3.6	3.3	6.5	5.1	4.6	4.2	2.4	2.0	2.5	1.8
P/B	3.7	4.5	5.1	4.4	7.8	8.7	6.7	5.1	2.9	2.5	2.8	2.0
P / Tangible Book	·	·	54.9	·	·	·	·	·	·	·	·	·
P / Cash Flow	16.8	23.8	15.3	18.9	52.4	32.1	28.0	17.4	13.3	14.7	18.0	12.0
P / FCF	21.4	37.5	25.6	43.1	79.4	46.4	110.7	26.3	25.4	92.4	460.7	25.4
EV / EBITDA	17.9	30.1	29.8	46.8	69.2	51.5	55.6	69.5	-118.4	-47.6	62.9	40.5
EV / FCF	27.8	43.0	28.6	49.9	86.6	48.7	115.2	26.8	27.5	107.4	514.6	29.1
EV / Revenue	2.9	3.8	4.0	3.8	7.1	5.4	4.8	4.3	2.6	2.3	2.8	2.0
Earnings Yield	5.2%	2.7%	2.7%	1.3%	1.4%	1.5%	1.2%	1.2%	-1.3%	-3.1%	0.72%	2.1%

Income Statement 16

Quarterly Income Statement data for HAE
Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2025	Q3 2024	Q2 2024	Q1 2024	Q4 2024	Q3 2023	Q2 2023	Q2 2023	Q4 2023	Q3 2022	Q2 2022	Q1 2022	Q4 2022
Revenue	$339M	$327M	$321M	$331M	$349M	$346M	$336M	$343M	$336M	$318M	$311M	$340M	$305M	$297M	$261M	$265M
Cost of Revenue	$137M	$133M	$129M	$138M	$155M	$158M	$161M	$167M	$158M	$148M	$144M	$169M	$147M	$140M	$119M	$129M
Gross Profit	$202M	$195M	$192M	$193M	$194M	$187M	$175M	$176M	$178M	$171M	$167M	$172M	$159M	$158M	$142M	$136M
R&D Expense	$14M	$15M	$16M	$18M	$16M	$14M	$14M	$16M	$13M	$13M	$13M	$16M	$13M	$11M	$11M	$13M
SG&A Expense	$109M	$102M	$111M	$115M	$106M	$107M	$108M	$111M	$112M	$115M	$93M	$98M	$95M	$92M	$92M	$92M
Operating Expenses	$135M	$136M	$138M	$122M	$135M	$136M	$135M	$146M	$132M	$135M	$114M	$121M	$115M	$111M	$111M	$117M
Operating Income	$67M	$58M	$54M	$71M	$59M	$52M	$40M	$30M	$46M	$35M	$54M	$51M	$43M	$47M	$31M	$19M
Other Non-op	$-7M	$-7M	$-9M	$-598.0K	$-9M	$-7M	$7M	$-7M	$-2M	$-2M	$-2M	$-3M	$-1M	$-6M	$-5M	$-4M
Pretax Income	$60M	$51M	$45M	$71M	$50M	$45M	$47M	$23M	$44M	$33M	$52M	$48M	$42M	$41M	$25M	$15M
Income Tax	$15M	$13M	$11M	$13M	$12M	$11M	$8M	$3M	$13M	$8M	$11M	$5M	$9M	$8M	$6M	$6M
Net Income	$45M	$39M	$34M	$58M	$37M	$34M	$38M	$20M	$31M	$25M	$41M	$42M	$33M	$33M	$20M	$10M
EPS (Basic)	$0.96	$0.81	$0.71	$1.17	$0.75	$0.66	$0.75	$0.40	$0.62	$0.49	$0.81	$0.84	$0.65	$0.65	$0.39	$0.20
EPS (Diluted)	$0.95	$0.81	$0.70	$1.17	$0.74	$0.66	$0.74	$0.40	$0.61	$0.48	$0.80	$0.84	$0.64	$0.64	$0.38	$0.19
Shares (Basic)	46,792,000	47,590,000	48,111,000	-101,797,000	50,286,000	50,898,000	50,943,000	27,000	50,768,000	50,727,000	50,542,000	-102,174,000	50,509,000	50,953,000	51,224,000	-102,025,000
Shares (Diluted)	46,987,000	47,664,000	48,353,000	-102,713,000	50,639,000	51,240,000	51,564,000	3,000	51,445,000	51,396,000	51,340,000	-103,165,000	51,219,000	51,558,000	51,683,000	-102,388,000
EBITDA	$67M	$58M	$54M	·	$59M	$52M	$40M	·	$46M	$35M	$54M	·	$43M	$47M	$31M	·

Balance Sheet 25

Quarterly Balance Sheet data for HAE
Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2025	Q3 2024	Q2 2024	Q1 2024	Q4 2024	Q3 2023	Q2 2023	Q2 2023	Q4 2023	Q3 2022	Q2 2022	Q1 2022	Q4 2022
Cash & Equivalents	$363M	$296M	$293M	$307M	$321M	$299M	$344M	$179M	$194M	$351M	$286M	·	$224M	$241M	$215M	·
Receivables	$196M	$207M	$201M	$203M	$212M	$214M	$201M	$207M	$212M	$174M	$177M	·	$181M	$172M	$146M	·
Inventory	$321M	$336M	$361M	$365M	$360M	$382M	$374M	$317M	$304M	$286M	$289M	·	$256M	$255M	$278M	·
Prepaid Expense	$63M	$60M	$59M	$60M	$113M	$61M	$59M	$66M	$55M	$55M	$50M	·	$45M	$48M	$48M	·
Current Assets	$944M	$900M	$913M	$935M	$1.01B	$956M	$979M	$769M	$765M	$866M	$802M	·	$706M	$716M	$688M	·
PP&E (Net)	$297M	$292M	$287M	$284M	$286M	$300M	$302M	$311M	$319M	$308M	$304M	·	$313M	$308M	$288M	·
PP&E (Gross)	$837M	$815M	$795M	$837M	$867M	$939M	$949M	$959M	$979M	$950M	$943M	·	·	·	·	·
Accum. Depreciation	$540M	$523M	$508M	$553M	$581M	$639M	$647M	$648M	$661M	$642M	$638M	·	·	·	·	·
Goodwill	$607M	$606M	$607M	$604M	$605M	$616M	$613M	$565M	$555M	$465M	$466M	$466M	$466M	$465M	$466M	$467M
Intangibles	$420M	$428M	$451M	$456M	$466M	$488M	$495M	$406M	$429M	$251M	$268M	·	$284M	$293M	$303M	·
Other Non-current Assets	$216M	$208M	$196M	$164M	$160M	$156M	$142M	$136M	$127M	$117M	$117M	·	$103M	$80M	$71M	·
Total Assets	$2.49B	$2.44B	$2.46B	$2.45B	$2.53B	$2.53B	$2.54B	$2.20B	$2.20B	$2.01B	$1.96B	·	$1.88B	$1.87B	$1.82B	·
Accounts Payable	$49M	$62M	$46M	$67M	$63M	$69M	$77M	$73M	$57M	$80M	$78M	·	$64M	$61M	$58M	·
Current Liabilities	$540M	$548M	$531M	$578M	$253M	$274M	$260M	$300M	$262M	$264M	$237M	·	$227M	$262M	$180M	·
Capital Leases	·	·	·	$50M	·	·	·	$58M	·	·	·	·	·	·	·	·
Deferred Tax	$56M	$58M	$59M	$63M	$61M	$63M	$65M	$63M	$62M	$35M	$37M	·	$40M	$36M	$33M	·
Other Non-current Liabilities	$64M	$66M	$68M	$68M	$90M	$90M	$92M	$75M	$76M	$70M	$72M	·	$78M	$78M	$74M	·
Long-term Debt	$1.22B	$1.22B	$1.22B	$1.25B	$1.22B	$1.22B	$1.22B	$808M	$871M	$762M	$765M	·	$767M	$818M	$770M	·
Total Debt	$1.22B	$1.22B	$1.22B	·	$1.22B	$1.22B	$1.22B	·	$871M	$762M	·	·	$767M	$818M	$770M	·
Common Stock	$468.0K	$467.0K	$482.0K	$482.0K	$502.0K	$504.0K	$512.0K	$508.0K	$508.0K	$507.0K	$507.0K	·	$504.0K	$506.0K	$513.0K	·
Retained Earnings	$381M	$336M	$356M	$352M	$392M	$369M	$387M	$360M	$340M	$309M	$284M	·	$224M	$204M	$222M	·
AOCI	$-35M	$-41M	$-36M	$-55M	$-56M	$-35M	$-43M	$-36M	$-24M	$-33M	$-30M	·	$-36M	$-40M	$-33M	$-26M
Stockholders' Equity	$911M	$849M	$882M	$821M	$907M	$879M	$905M	$960M	$943M	$894M	$865M	$818M	$776M	$729M	$770M	$749M
Liabilities + Equity	$2.49B	$2.44B	$2.46B	$2.45B	$2.53B	$2.53B	$2.54B	$2.20B	$2.20B	$2.01B	$1.96B	·	$1.88B	$1.87B	$1.82B	·
Shares Outstanding	46,829,249	46,747,381	48,158,723	48,215,899	50,235,051	50,381,127	51,152,886	50,787,859	50,785,040	50,740,389	50,705,779	·	50,444,470	50,605,499	51,315,653	·

Cash Flow 13

Quarterly Cash Flow data for HAE
Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2025	Q3 2024	Q2 2024	Q1 2024	Q4 2024	Q3 2023	Q2 2023	Q2 2023	Q4 2023	Q3 2022	Q2 2022	Q1 2022	Q4 2022
D&A	$27M	$28M	$29M	$28M	$29M	$29M	$29M	$28M	$24M	·	$23M	$24M	$24M	·	$22M	$25M
Stock-based Comp	$8M	$8M	$9M	$7M	$8M	$7M	$8M	$7M	$7M	·	$7M	$7M	$7M	·	$5M	$5M
Deferred Tax	$-2M	$-725.0K	$-3M	$3M	$-2M	$-2M	$-4M	$-6M	$-3M	·	·	·	·	·	·	$3M
Amort. of Intangibles	$12M	$13M	$13M	$13M	$14M	$14M	$14M	$13M	$9M	$9M	$10M	$15M	$10M	$11M	$8M	$21M
Restructuring	$1M	$204.0K	$1M	$984.0K	$4M	$5M	$5M	$6M	$8M	$86.0K	$-11.0K	$701.0K	$44.0K	$165.0K	$-44.0K	$194.0K
Operating Cash Flow	$94M	$111M	$17M	$117M	$44M	$49M	$-27M	$64M	$-540.0K	·	$19M	$80M	$64M	·	$42M	$68M
CapEx	$6M	$5M	$4M	$16M	$9M	$9M	$6M	$7M	$-3M	·	$8M	$93M	$17M	·	$45M	$35M
Investing Cash Flow	$-29M	$-30M	$-33M	$18M	$-17M	$-23M	$-139M	$-13M	$-269M	·	$-15M	$-18M	$-36M	·	$-58M	$-35M
Net Debt Issued	·	·	$-2M	·	·	·	$-2M	·	·	·	$-2M	·	·	·	$-4M	·
Stock Repurchased	$0	·	·	$150M	$0	·	·	$0	$0	·	·	$0	$0	·	·	$0
Financing Cash Flow	$2M	$-77M	$-2M	$-151M	$1M	$-75M	$334M	$-64M	$109M	·	$-598.0K	$-2M	$-50M	·	$-23M	$-9M
Net Change in Cash	$67M	$4M	$-14M	$-14M	$22M	$-45M	$166M	$-15M	$-157M	·	$1M	$60M	$-17M	·	$-45M	$23M
Free Cash Flow	·	·	$14M	·	·	·	$-33M	·	·	·	$9M	·	·	·	$-3M	·

Profitability 8

Quarterly Profitability data for HAE
Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2025	Q3 2024	Q2 2024	Q1 2024	Q4 2024	Q3 2023	Q2 2023	Q2 2023	Q4 2023	Q3 2022	Q2 2022	Q1 2022	Q4 2022
Gross Margin	59.7%	59.5%	59.8%	·	55.5%	54.2%	52.0%	·	52.9%	53.6%	53.7%	·	52.0%	53.1%	54.4%	·
Operating Margin	19.9%	17.9%	16.8%	·	16.9%	15.0%	11.8%	·	13.7%	11.1%	17.2%	·	14.2%	15.7%	11.8%	·
Net Margin	13.2%	11.8%	10.6%	·	10.8%	9.8%	11.4%	·	9.3%	7.8%	13.2%	·	10.8%	11.2%	7.6%	·
Pretax Margin	17.7%	15.7%	14.1%	·	14.3%	12.9%	13.9%	·	13.1%	10.3%	16.6%	·	13.8%	13.8%	9.8%	·
EBITDA Margin	19.9%	17.9%	16.8%	·	16.9%	15.0%	11.8%	·	13.7%	11.1%	17.2%	·	14.2%	15.7%	11.8%	·
ROA	1.8%	1.6%	1.4%	·	1.6%	1.5%	1.7%	·	1.5%	1.3%	·	·	1.8%	1.8%	1.1%	·
ROE	4.9%	4.5%	3.8%	·	4.0%	3.8%	4.3%	·	3.6%	3.1%	·	·	4.4%	4.7%	2.8%	·
ROIC	2.4%	2.1%	1.9%	·	2.1%	1.9%	1.5%	·	1.8%	1.6%	·	·	2.2%	2.4%	1.6%	·

Liquidity & Solvency 4

Quarterly Liquidity & Solvency data for HAE
Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2025	Q3 2024	Q2 2024	Q1 2024	Q4 2024	Q3 2023	Q2 2023	Q2 2023	Q4 2023	Q3 2022	Q2 2022	Q1 2022	Q4 2022
Current Ratio	1.7	1.6	1.7	·	4.0	3.5	3.8	·	2.9	3.3	·	·	3.1	2.7	3.8	·
Quick Ratio	1.0	0.9	0.9	·	2.1	1.9	2.1	·	1.5	2.0	·	·	1.8	1.6	2.0	·
Debt / Equity	1.3	1.4	1.4	·	1.4	1.4	1.4	·	0.9	0.9	·	·	1.0	1.1	1.0	·
LT Debt / Equity	1.0	1.1	1.0	·	1.3	1.4	1.3	·	0.9	0.8	·	·	1.0	1.0	1.0	·

Efficiency 3

Quarterly Efficiency data for HAE
Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2025	Q3 2024	Q2 2024	Q1 2024	Q4 2024	Q3 2023	Q2 2023	Q2 2023	Q4 2023	Q3 2022	Q2 2022	Q1 2022	Q4 2022
Asset Turnover	0.1	0.1	0.1	·	0.1	0.2	0.1	·	0.2	0.2	·	·	0.2	0.2	0.1	·
Inventory Turnover	0.4	0.4	0.4	·	0.5	0.5	0.5	·	0.6	0.5	·	·	0.5	0.5	0.4	·
Receivables Turnover	1.7	1.6	1.6	·	1.6	1.8	1.8	·	1.7	1.8	·	·	1.8	1.9	1.9	·

Per Share 5

Quarterly Per Share data for HAE
Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2025	Q3 2024	Q2 2024	Q1 2024	Q4 2024	Q3 2023	Q2 2023	Q2 2023	Q4 2023	Q3 2022	Q2 2022	Q1 2022	Q4 2022
Book Value / Share	$19.46	$18.17	$18.32	·	$18.05	$17.44	$17.70	·	$18.57	$17.61	·	·	$15.38	$14.41	$15.01	·
Revenue / Share	$7.21	$6.87	$6.65	·	$6.88	$6.74	$6.52	·	$6.54	$6.19	$6.06	·	$5.96	$5.77	$5.06	·
Cash Flow / Share	·	·	$0.36	·	·	·	$-0.53	·	·	·	$0.37	·	·	·	$0.81	·
Cash / Share	$7.76	$6.34	$6.08	·	$6.39	$5.94	$6.73	·	$3.82	$6.92	·	·	$4.44	$4.77	$4.19	·
EPS (TTM)	$3.20	$2.91	$2.84	·	$2.75	$2.49	$2.63	·	$2.53	$2.56	$2.72	·	·	·	$1.50	·

Valuation (TTM) 14

Quarterly Valuation (TTM) data for HAE
Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2025	Q3 2024	Q2 2024	Q1 2024	Q4 2024	Q3 2023	Q2 2023	Q2 2023	Q4 2023	Q3 2022	Q2 2022	Q1 2022	Q4 2022
Revenue TTM	$1.34B	$1.34B	$1.35B	·	$1.37B	$1.34B	$1.30B	·	$1.27B	$1.23B	$1.21B	·	·	·	$1.02B	·
Net Income TTM	$155M	$144M	$144M	·	$141M	$128M	$136M	·	$130M	$132M	$140M	·	·	·	$78M	·
Market Cap	$3.76B	$2.25B	$3.55B	·	$3.90B	$4.02B	$4.23B	·	$4.34B	$4.55B	·	·	$3.97B	$3.75B	$3.45B	·
Enterprise Value	$4.62B	$3.18B	$4.49B	·	$4.80B	$4.95B	$5.11B	·	$5.02B	$4.96B	·	·	$4.51B	$4.32B	$4.01B	·
P/E	25.1	16.6	26.0	·	28.2	32.0	31.5	·	33.8	35.0	31.3	·	·	·	44.9	·
P/S	2.8	1.7	2.6	·	2.9	3.0	3.3	·	3.4	3.7	·	·	·	·	3.4	·
P/B	4.1	2.7	4.0	·	4.3	4.6	4.7	·	4.6	5.1	·	·	5.1	5.1	4.5	·
P / Tangible Book	·	·	·	·	·	·	·	·	·	25.6	·	·	155.7	·	2161.8	·
P / Cash Flow	·	·	204.3	·	·	·	-154.3	·	·	·	·	·	·	·	82.3	·
P / FCF	·	·	260.5	·	·	·	-127.9	·	·	·	·	·	·	·	-994.4	·
EV / EBITDA	68.6	54.4	83.3	·	81.3	95.7	128.6	·	109.2	140.4	·	·	104.2	92.5	130.3	·
EV / FCF	·	·	328.9	·	·	·	-154.5	·	·	·	·	·	·	·	-1154.2	·
EV / Revenue	3.5	2.4	3.3	·	3.5	3.7	3.9	·	3.9	4.0	·	·	·	·	3.9	·
Earnings Yield	4.0%	6.0%	3.9%	·	3.5%	3.1%	3.2%	·	3.0%	2.9%	3.2%	·	·	·	2.2%	·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Income Statement

	2025-03-29	2024-03-30	2023-04-01	2022-04-02	2021-04-03
Revenue	$1.36B	$1.31B	$1.17B	$993M	$870M
Gross Margin %	55.0%	52.8%	52.6%	50.9%	45.7%
Operating Margin %	16.3%	12.6%	13.4%	8.1%	10.3%
Net Income	$168M	$118M	$115M	$43M	$79M
Diluted EPS	$3.31	$2.29	$2.24	$0.84	$1.55

Balance Sheet

	2025-03-29	2024-03-30	2023-04-01	2022-04-02	2021-04-03
Debt / Equity	1.5	0.8	0.9	1.0	1.0
Current Ratio	1.6	2.6	3.1	1.7	2.7
Quick Ratio	0.9	1.3	1.8	0.9	1.3

Cash Flow

	2025-03-29	2024-03-30	2023-04-01	2022-04-02	2021-04-03
Free Cash Flow	$142M	$115M	$163M	$76M	$72M

Latest News Recent headlines mentioning this company

Haemonetics Q4 Earnings Call Highlights Yahoo Finance · 1 week, 2 days ago
Riverwater Sustainable Value Strategy Awaits Haemonetics Corporation’s (HAE) Market Validation Yahoo Finance · 4 weeks, 1 day ago

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

HAE Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

HAE Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

Moving averages & overlays

Volume

Oscillators

Momentum & trend

10-Year Performance Revenue, net income, margins and EPS trends

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Financial Health Debt, liquidity, solvency — balance sheet strength

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

HAE Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

12-Month Price Target

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Peer Comparison Key metrics vs sector peers

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Latest News Recent headlines mentioning this company

My Metrics Your personal watchlist — selected rows from Full Fundamentals